PGNY
Progyny
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 3
Sell signal 2
Stock Price Surged Significantly
Ample Liquidity
EPS Beats Expectation
RSI Overbought
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PGNY
Progyny, Inc.
A leading fertility benefits management company
Healthcare Providers and Services
04/03/2008
10/25/2019
NASDAQ Stock Exchange
675
12-31
Common stock
1359 Broadway, New York, New York 10018
--
Progyny, Inc., was incorporated in Delaware on April 3, 2008. Progyny, Inc., is a leading benefits management company specializing in fertility and family building benefits solutions. The company's mission is to realize the dream of parenting through a healthy, timely and supportive reproductive journey. Through the company's differentiated approach to benefit plan design, patient education and support, and active network management, its clients' employees are able to seek the most effective treatments and achieve the best outcomes from the best physicians.
Earnings Call
Q1/2025
Estimate EPS0.45
Actual EPS0.48
Estimate Revenue307.82M
Actual Revenue324.04M
Progyny's Q1 2025 Earnings Call: Unpacking Contradictions in Seasonality, Margins, and Amazon's Impact on Utilization
May 19,2025 06:28
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
PGNY has released its 2025 Q1 earnings. EPS was reported at 0.48, versus the expected 0.45, beating expectations. The chart below visualizes how PGNY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PGNY has released its 2025 Q1 earnings report, with revenue of 324.04M, reflecting a YoY change of 16.53%, and net profit of 15.06M, showing a YoY change of -10.88%. The Sankey diagram below clearly presents PGNY's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
